4Accepted Aug 18, 4:15 PM ET
Astrana Health (ASTH) Director David Schmidt Exercises Options, Sells Shares
Accepted (ET)
4:15 PM
Aug 18, 2026
Filed
Aug 18, 2026
Documents
1
Size
9.1 KB
Summary
Astrana Health (ASTH) Director David Schmidt Exercises Options, Sells Shares
What Happened
- David Schmidt, a director of Astrana Health (ASTH), exercised stock options and disposed of shares on August 14, 2026. He exercised 20,000 options at $5.00 per share (cost $100,000) and those 20,000 shares were disposed to the issuer at $38.59 each for total proceeds of $771,800 (net proceeds ≈ $671,800 before fees/taxes). The Form 4 also reports a separate 20,000-share derivative conversion/exercise showing $0.00 consideration and a $0 disposition amount. Footnote in the filing states these shares were repurchased by the issuer.
Key Details
- Transaction date: August 14, 2026
- Reported filings: Form 4 filed August 18, 2026 (filed 4 days after the transaction date — appears to be a late filing)
- Transactions and values:
- M (option exercise): 20,000 shares @ $5.00 — cost $100,000
- D (disposition to issuer): 20,000 shares @ $38.59 — proceeds $771,800
- M (exercise/conversion) reported for 20,000 shares @ $0.00 — $0 reported
- Footnotes of note:
- F1: The shares were repurchased by the issuer (explains the disposition to the issuer).
- F2: The filing notes 4,525 shares of restricted stock included in holdings will vest on the earlier of June 10, 2027 or the 2027 annual meeting.
- F3: The options exercised were fully vested and exercisable.
- Shares owned after the reported transactions are not specified in the provided filing excerpt.
Context
- This was effectively an option exercise followed by an immediate disposition back to the issuer (a repurchase), which is often executed as a cashless or sell-to-cover style transaction — the filing shows the exercise cost and the sale proceeds separately. The extra line showing a $0.00 exercise/disposition likely reflects a conversion/derivative handling noted in the filing; the footnote confirms repurchase by the issuer.
- Filing timeliness: The Form 4 was filed after the typical two-business-day window for reporting insider trades, so the filing is marked late; the filing does not explain the delay.